Ensuring Excellence: Quality Control of Raw & Starting Materials for mRNA-Based Therapeutics
Time: 11:00 am
day: Day One
Details:
- What specific attributes of mRNA raw materials are evaluated during quality control processes, and how do these attributes influence the safety and efficacy of the final product?
- What are the established regulatory guidelines for quality control of mRNA raw materials?
- What strategies are being explored to address challenges related to batch-to-batch variability and quality assurance?
